Purpose: To correlate angiogenic cytokines in the aqueous humour with total retinal blood flow in subjects with type 2 diabetes with non-proliferative diabetic retinopathy (NPDR). Methods: A total of 17 controls and 16 NPDR patients were recruited into the study. Aqueous humour was collected at the start of cataract surgery to assess the concentration of 14 angiogenic cytokines. Aqueous humour was analysed using the suspension array method. Six images were acquired to assess total retinal blood flow (TRBF) using the prototype RTVue TM Doppler Fourier domain optical coherence tomography (Doppler FD-OCT) (Optovue, Inc., Fremont, CA) using a double circular scan protocol, 1 month postsurgery. At the same visit, forearm blood was collected to determine glycosylated haemoglobin (A1c). Results: Transforming growth factor beta (TGF-b1, TGF-b2) and PLGF were increased while FGF-1 was reduced in NPDR compared to controls (Bonferroni corrected, p < 0.003 for all). Total retinal blood flow (TRBF) was significantly reduced in the NPDR group compared to controls (33.1 AE 9.9 versus 43.3 AE 5.3 ll/ min, p = 0.002). Aqueous FGF-1 significantly correlated with TRBF in the NPDR group (r = 0.71, p = 0.01; r 2 = 0.51). In a multiple regression analysis, A1c was found to be a significant predictor of aqueous TGF-b1 and FGF-1 (p = 0.018 and p = 0.020, respectively). Conclusion: Aqueous angiogenic cytokines (TGF-b1, TGF-b2 and PLGF) were elevated in conjunction with a reduction in TRBF in patients with NPDR compared to controls. Non-invasive measurement of TRBF may be useful for predicting aqueous FGF-1 levels and severity of vasculopathy in DR.
Introduction
Diabetic retinopathy (DR) is a sight threatening complication of diabetes mellitus and is currently the leading cause of blindness in working age adults (Antonetti et al. 2012) . Following 20 years of diabetes, nearly all patients with type 1 and type 2 diabetes mellitus will sufferfrom some form of retinopathy (Klein & Klein 2010; Yau et al. 2012) . Using non-invasive measurement techniques, animal and human studies have reported alterations in retinal blood flow before any clinical signs of DR (Grunwald et al. 1986; Bursell et al. 1996; Takagi et al. 1996) . Although perturbations in retinal blood flow are hypothesized to be an early hallmark of DR, the role of diabetes-induced alterations that modulate retinal blood flow in early DR are still unknown. To assess the pathogenesis of DR, as well as to provide clinical biomarkers of DR severity, we set out to examine the role of angiogenic cytokines during diabetes-induced microvascular disturbances in early DR.
The role of angiogenic cytokines in the progression DR has been reported by many groups (Clermont et al. 1997; Noma et al. 2009 Noma et al. , 2010 . Moreover, previous studies have demonstrated that angiogenic cytokines are elevated in the ocular fluid of eyes affected by DR (Oh et al. 2010; Chiang et al. 2012; Dong et al. 2013 ) and diabetic macular oedema (Jonas et al. 2012; Lee et al. 2012 ) compared with control eyes. Recently, aqueous humour (AH) vascular endothelial growth factor (VEGF) was found to be associated with retinal blood flow in patients with central retinal vein occlusion (Yamada et al. 2015) . More recently, the use of multiplex bead analysis allows for simultaneous analysis of multiple cytokines in small volumes and provides broader insight into the mechanisms involved in retinal hemodynamic alterations in early DR.
An established technique that has been used to investigate volumetric retinalblood flowin DRis bidirectionallaser Doppler velocimetry with simultaneous vessel densitometry. However, this technique is currently limited to large vessels and one single measurement site. Subsequently, Doppler spectral Fourierdomain optical coherence tomography (Doppler FD-OCT) blood flow (i.e. Optovue RTVue) has been developed to evaluate volumetric total retinal blood flow (TRBF). The FD-OCT system uses low coherence light to measure the total retinal blood flow of all vessels around the optic nerve head (Wang et al. 2008) . This system has been proven to reliably and consistently measure retinal blood flow in both healthy (Tayyari et al. 2014) and subjects with DR (Wang et al. 2009a ). Thus, the Optovue system is a convenient method for measuring blood flow perturbations in DR and can be used clinically to assess DR severity.
Unlike previous studies which examine the role of angiogenic cytokines in patients with advanced proliferative DR (Jonas et al. 2012 , Noma et al. 2010a , we set out to evaluate the levels of angiogenic cytokines in the aqueous humour in non-proliferative diabetic retinopathy (NPDR) to ascertain if changes in these locally produced factors vary in patients with early NPDR. Further, we investigated the relationship between angiogenic cytokines and TRBF in patients with NPDR. Noninvasive quantification of TRBF may be a novel biomarker for biochemical alterations in early DR.
Subjects and Methods

Sample
All eligibility was determined and confirmed by an ophthalmologist during slit-lamp examination. Participants had to be eligible for phacoemulsification. The subjects was composed of two groups: 15 non-diabetic control subjects (mean age 68.0 AE 6.32 years) and 15 patients with diabetes with mild NPDR and Early Treatment of Diabetic Retinopathy Study (ETDRS) <20 points (67.5 AE 10.1 years with mean duration of diabetes 12.2 AE 13.0 years). The definition of mild NPDR was based on risk factors identified in the ETDRS for the development of macular edema (Anonymous 1991) and included patients with microaneuryms only. All subjects in the NPDR group were non-insulin dependent (NIDDM) with Type 2 diabetes mellitus. Subjects were excluded from the study if they had any clinical evidence of ocular disease (other than DR) and/or a history of ocular surgery or laser procedure. Subjects with a history of glaucoma in a first-degree relative were excluded from the study. Subjects taking medications with known effects on blood flow (except for well controlled systemic hypertension) and subjects with rheumatologic diseases were excluded. None of the subjects smoked or had any respiratory diseases. This study was approved by the University Health Network Research Ethics Board, University of Toronto Research Ethics Board and Kensington Eye Institute Research Ethics Board. Informed consent was obtained from each participant after thorough explanation of the nature of the study and its possible consequences, according to the tenets of the Declaration of Helsinki.
Aqueous humour collection
At the time of surgery, paracentesis was made in the peripheral cornea next to the limbus and undiluted samples of AH (80-120 ll) were obtained from all participants. During the collection, the tip of the cannula was carefully placed in the mid anterior chamber and AH was slowly aspirated until the anterior chamber began to shallow. Care was taken to avoid touching intraocular tissues and to prevent contamination of aqueous samples with blood. The AH was collected into an attached tuberculin syringe and then subsequently deposited into a 1.5-ml microtube and placed on dry ice. The AH sample was immediately stored in a À80°C refrigerator until analysis was performed. The aqueous samples were thawed at room temperature, vortexed, and then spun at 13 000 g for 5 min to remove any precipitates. Aqueous humour (AH) samples were then separated into aliquots of 30 ll. ), angiopoietins (ANG-2), interleukin-8 (IL-8), leptin, stromal-derived factor-1, epidermal growth factor (EGF), transforming growth factorbeta (TGF-b1 and TGF-b2), granulocyte colony stimulating factor (G-CSF) platelet-derived growth factors (PDGFs), vascular endothelial growth factor (VEGF), erythropoietin, endothelin-1 (ET-1), insulin (Millipore, St. Charles, MO, USA). The sensitivities of the markers range from 0.2 to 17.0 pg/ml. Individual analyte values and other assay details are available on Eve Technologies' website or in the Milliplex protocol. The tests were performed in accordance with the manufacturer's instructions. An analyte was considered 'detectable' if the levels exceeded the minimal detectable levels identified in manual.
Quantifying total retinal blood flow using FD-OCT Four weeks postsurgery, clinical procedures were repeated to confirm that DR severity is unchanged for each participant. At the same visit, the study eye was dilated with 1% tropicamide and 2.5% phenylephrine eye drops and images were then acquired. Doppler optical coherence tomography (OCT) images were taken using the commercially available instrument known as the RTVue Doppler OCT (Optovue Inc, Freemont, CA, USA). The assessment included six sets of two concentric circular scans (each 3.4 and 3.75 mm in diameter, centred on the optic nerve head).
Non-invasive OCT technology has utilized Doppler FD-OCT to extract information to calculate the volumetric blood flow. A computer algorithm chooses candidate vessels followed by manual refining by human operators, using the Doppler OCT of Retinal Circulation (DOCTORC) grading software. The tissue surrounding the vessel does not give a Doppler signal, delineating the vessel from the rest of the retina. The computer defines the candidate vessel used in the determining TRBF. In the postanalysis process, the operator compares the initial automated processing with a colour fundus image to help accurately determine the distribution of vessels. The operator also adjusts the vessel assignment (arteriole or venule) and evaluates the Doppler signal size and intensity to precisely calculate total retinal blood flow. Since TRBF is determined by the sum of flow in the retinal venules, correct vessel assignment is pertinent to accurate measurement of TRBF. Since this software is semi-automated, it takes an experienced technician 30-50 min per eye for analysis. This method has been previously described and has been recently validated (Wang et al. 2008; Tan et al. 2012; Tayyari et al. 2014) .
Finally, the TRBF is corrected by axial length. In Doppler OCT, the scan is actually based on a model eye with axial length of 24 mm and is found to vary with different eye lengths. Longer axial lengths decrease the magnification of the fundus image, reduce the transverse diameter of the vessel and increase the apparent Doppler angle, making the velocity and flow appear artifactually low. However, this magnification can be corrected. As described by Srinivas et al. (2015) , corrected TRBF can be obtained using the formula: corrected TRBF = oTRBF 9 (axial length/ default axial length) 2 . Here, oTRBF is the original total retinal blood flow before eye length correction and the default axial length, which is a value of 24 mm. The axial length-corrected TRBF wasused in thestatistical analyses.
Briefly, the RTVue system has a light source of 840 nm with a bandwidth of 50 nm, an axial resolution of 5 lm in tissue and a transverse resolution of 20 lm (Wang et al. 2011) . The Doppler OCT is based on the principle that moving particles, such as a red blood cell inside a blood vessel, causes a Doppler frequency shift (Δf) to the scattered light. The Doppler shift (Δf) is proportional to the flow velocity (V) component to the axis of the probe beam. The Doppler shift (Δf) and angle a is measured from the difference between two concentric circular OCT scans. The measured Doppler shift, the incident angle and vessel area are used to calculate blood flow in each vessel. Total retinal blood flow was measured by summing the flow of all the detectable veins. Since retinal circulation is an end-arterial system without anastomoses, retinal blood flow in arteries and veins should have equal sum because the inflow must equal the outflow in any steady state system that obeys the law of conservation of mass. Feke & Riva (1978) confirmed that retinal flow in arterioles is equal to the retinal flow in veins due to a steady state system. Thus, measuring total venous flow alone is sufficient to quantify the total retinal blood flow.
Statistical analysis
All analyses were performed with STA-TISTICA SYSTEM 11.0 software (SAS Institute Inc., Cary, NC, USA). All results are presented as the mean AE standard deviation (SD). The mean fold changes of the detected biomarkers were calculated between NPDR and control subjects. Differences in total retinal blood flow and aqueous humour factor components between healthy and NPDR participants were assessed with Student's t-test. The correlation between TRBF and aqueous humour cytokines was determined with Pearson Bivariate Correlation test. A Bonferroni correction was applied to each p-value according to the number of comparisons in this study (corrected p-value of 0.05/14 = 0.003). For the correlation analyses, Bonferroni correction was applied to make the level of significance, p < 0.01.
Results
The demographic data of subjects are shown in Table 1 . A total of 18 controls and 16 NPDR patients were initially recruited for the study. NPDR participants had early signs of retinopathy including microaneurysms, as confirmed by the ophthalmologist. Of the 16 NPDR subjects who provided aqueous humour samples at the time of surgery, 15 completed the follow-up and had flow data of adequate quality to be included in the analysis. Of the controls, 17 subjects had returned for follow-up imaging and were included in the analysis.
Retinal blood flow findings Table 2 lists the mean (AEstandard deviation (SD)) corrected TRBF for the control and NPDR groups. The mean TRBF for controls was 43.3 AE 5.3 ll/ min (95% CI: 40.2-46.3 ll/min) and 33.1 AE 9.9 ll/min (95% CI: 27.1-39.1 ll/min) for NPDR patients. NPDR patients had significantly lower TRBF (~22%) than control subjects (p = 0.002). Compared to controls, NPDR patients had significantly reduced superior and inferior retinal blood flow rates (~23%; p = 0.01 and p = 0.02, respectively). Table 3 lists the results of our analysis of 14 candidate biomarkers in the aqueous humour samples of healthy control and NPDR subjects using suspension array analysis. Due to low aqueous sample volumes, only 11 controls and eight NPDR samples were analysed for aqueous TGF-b1 and TGF-b2.
Aqueous humour findings
Correlations between TRBF and aqueous humour cytokines
Aqueous FGF-1 was significantly correlated with the TRBF across all participants with a correlation coefficient of r = 0.59, p = 0.001, r 2 = 0.34. Within the NPDR group, aqueous FGF-1 remained significantly associated with TRBF with a correlation coefficient of r = 0.71, p = 0.013, r 2 = 0.51, Fig. 1 . The results also revealed a significant association between aqueous TGF-b1 and TRBF with a correlation coefficient of r = À0.64 (p = 0.005) across all subjects. In the NPDR group, however, aqueous TGF-b1 was not associated with TRBF (r = À0.65, p = 0.11).
Aqueous VEGF, ANG-2, ET-1, insulin factors were not significantly correlated with TRBF (p > 0.114 for all). Forearm A1c was associated with TRBF across all patients (r = À0.42, p = 0.023).
Multiple regression analysis
A multivariate model was fitted for aqueous TRBF and included predictor variables ANG-2, ET-1, FGF-1 and TGF-b1 in the NPDR group (F = 5.37, df = 4,7 and p = 0.027). The only significant predictor for TRBF was aqueous FGF-1 (b* = 0.806, p = 0.003). Additionally, a multivariate model was fitted for aqueous FGF-1 (F = 5.42, df = 3,21 and p = 0.006) and TGF-b1 (F = 2.81, df = 5,24 and p = 0.0387). The only significant predictor for aqueous FGF-1 and TGF-b1 was A1c (p = 0.020 and p = 0.018, respectively).
Discussion
Although retinal blood flow abnormalities are an early hallmark of DR, the precise mechanism for blood flow dysfunction has not been clear. Using the Doppler OCT, we report a reduction in TRBF in patients with NPDR compared to controls. In patients with NPDR, aqueous TGF-b1 and PLGF levels were significantly elevated while aqueous FGF-1 levels were decreased compared to controls. Our results reveal a moderate association between aqueous FGF-1 with TRBF in patients with NPDR. Although alterations in retinal hemodynamics have previously been found to be associated with increased aqueous humour growth factor expression in advanced retinal ischaemic diseases (Noma et al. 2009 (Noma et al. , 2010 Yamada et al. 2015) , this is the first study to point to a role of FGF-1 in impaired retinal blood flow in early DR. Overall, measurement of TRBF using Doppler OCT may be useful for predicting aqueous FGF-1 levels and severity of hemodynamic disturbances in early DR.
We observed a significant increase in TGF-b1 and PLGF in the aqueous humour of patients with NPDR compared to controls. Although not significant after Bonferroni corrections, additional angiogenic cytokines ANG-2, HGF and EGF tended to increase in the NPDR compared to controls (p < 0.023). In diabetics with DR, increased TGF-b1 in the aqueous humour has been previously reported. (Chiang et al. 2012; Dong et al. 2013; Oh et al. 2010 ) despite the lack of correlation between TGF-b and PLGF and TRBF, the aqueous profile from these eyes showed a marked similarity to those with PDR and was significantly distinct from the controls. These results lend further support that angiogenic growth factors not only have a role in PDR but mediate early vascular changes in early DR.
To the best of our knowledge, this is the first study to demonstrate an association between FGF-1 and retinal blood flow perturbations in DR. As administration of FGF-1 and FGF-2 lowers blood pressure (Cuevas et al. 1991) , both FGF-1 and FGF-2 have shown to play a part in the maintenance of vascular tone. In non-ocular models, reduced plasma FGF levels have been found to correlate with a reduction in peripheral blood flow in type 2 diabetic patients (Alrouq et al. 2014) . In experimental models, FGF has been shown to stimulate vasodilation and improve blood flow perfusion in animal models of ischaemia through NO mediated mechanisms (Wu et al. 1996) . Moreover, studies demonstrate that FGF stimulation is required for the maintenance of vascular system integrity and therefore, plays a Table 3 . List of aqueous humour cytokines as a function of group. Aqueous humour cytokines included fibroblast growth factor (FGF-1 and FGF-2), angiopoietins (ANG-2), interleukin-8 (IL-8), leptin, stromal-derived factor-1, epidermal growth factor (EGF), transforming growth factorbeta (TGF-b1 and TGF-b2), granulocyte colony stimulating factor (G-CSF) platelet-derived growth factors (PDGFs), vascular endothelial growth factor (VEGF), erythropoietin, endothelin-1 (ET-1), insulin. protective role in maintaining vascular tone. (Cuevas et al. 1998; Murakami et al. 2008; Hatanaka et al. 2012) . As diabetes has been found to impair the expression of endogenous FGFs (Yeboah et al. 2007 ), low FGF expression may explain the decreased retinal blood flow observed in early DR. These findings suggest FGF-1 may be a contributing factor for the observed reduction in TRBF and may be predisposing for diabetic vascular diseases. Decreases in retinal blood flow have been found in animal and humans with early diabetes (Sinclair et al. 1982; Grunwald et al. 1986; Nagaoka et al. 2010) . Using FD-OCT, Wang et al. (2009a) report reduced TRBF in patients with DM without retinopathy compared to normal controls. The range of TRBF values found in this study is within the previously reported TRBF range (Wang et al. 2009b; Shahidi et al. 2014; Tayyari et al. 2014 ). This and other corroborating studies Clermont et al. 1997; Wang et al. 2009a ) provide evidence that impaired retinal blood flow is a characteristic in early DR. The mechanisms mediating changes in retinal blood flow may be associated with vascular endothelial dysfunction, relating to augmented synthesis or action of vasodilators and increased expression and action of vasoconstrictors. The resultant shift in endothelial derived factors disrupts the homeostasis and shifts homoeostasis to a net vasoconstrictive effect in early diabetes. We have shown that the expression of ET-1 is increased while FGF-1 is decreased in the NPDR group compared to controls. Thus, an increased ET-1 and reduced FGF-1 production in the ocular tissue of diabetic patient may explain the decreased retinal blood flow in patients with early DR.
The simultaneous alteration in retinal hemodynamics and increase in angiogenic cytokine expression found in this study is consistent with the hypothesis that hyperglycaemiainduced activation of several activated pathways may mediate diabetesinduced retinal vascular dysfunction in diabetes. There is sufficient evidence in animal and human studies that show that hyperglycaemia initiates the development of DR and increase the synthesis, angiogenic activity (Joussen et al. 2001 ) and ultimately lead to retinal vascular abnormalities. As shown in our multiple regression analysis, a significant determinant of aqueous FGF-1 and TGF-b1 levels is A1c. A1c is a well-known contributor to metabolic pathways involved in DR progression (Stratton et al. 2001) . Longer studies that will allow the development of retinal blood flow changes and evaluation of the role of cytokines and growth factors, as well as inflammatory factors, will be required to reach firm conclusions.
The present study has its limitations. One limitation is that the cytokines released into the aqueous humour may differ due to the underlying cataract condition. However, we attempted to mitigate this issue as we compared the level of cytokines amongst all patients who underwent the same cataract procedure. This reduced the likelihood of differences in cytokine levels between groups. Additionally, our multiplex bead kits limited our analysis to growth factors and cytokine and did not include soluble receptor analysis. Soluble receptors have been shown to play an important role in modulating cytokine activity. Soluble forms of the FGFR1 have been found in the vitreous (Hanneken & Baird 1995) and binding of FGF1 and FGF2 to FRFR1 may inhibit the biological activity, acting in an agonistic manner. Furthermore, our study was limited to a 4-week follow-up TRBF measurement period in which TRBF may have undergone fluctuations due to the cataract surgery. Measurement of retinal blood flow 4 weeks postsurgery could be a more accurate reflection of the homoeostatic environment imposed by diabetes rather than change secondary to cataract surgery itself.
Overall, low TRBF was associated with low aqueous FGF-1 levels in patients with NPDR. Additionally, aqueous angiogenic factors (TGF-b1, TGF-b2 and PLGF) were elevated in conjunction with a reduction in TRBF in patients with NPDR. This study provides evidence that angiogenic factors may be involved in early retinal blood flow abnormalities in DR and provides a link between aqueous biomarkers and retinal vascular disorders in diabetes. This study suggests that measurement of TRBF using FD-OCT may be useful for determining aqueous FGF-1 levels and severity of vascular dysfunction in early DR. Aqueous FGF-1 (ng/ml) Fig. 1 . Scatter plot of corrected total retinal blood flow (TRBF) and aqueous humour cytokines fibroblast growth factor-1 (FGF-1) in NPDR subjects. The correlation between TRBF and FGF-1 was found to be r = 0.71, p = 0.01; r 2 = 0.51, FGF-1 = 1.9632 + 0.0933 9 x. Pearson bivariate correlation analysis was used to determine the relationship between aqueous humour cytokines.
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